METis TechBio

Hangzhou, China · Founded 2020 · In IPO Registration

Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. METis TechBio is based in Hangzhou, China and was founded in 2020. It has raised $315 million.

Last price · $/share
—
Implied valuation
—
Total raised
$314.7M
Last round
—

Who backs METis TechBio?

19 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

METis TechBio investors

19 investors are on record for METis TechBio, including HSG (Hong Kong), CICC Capital, Beijing State-owned Capital Operation and Management and 5Y Capital.

Free account
More of METis TechBio with a free account
  • ·The complete investor list: 19 names
  • ·Watch METis TechBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like METis TechBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View